Mateon Therapeutics Provides Business Update and Reports 2017 Financial Results

Mateon Therapeutics Provides Business Update and Reports 2017 Financial Results Press Release from GlobeNewsWire has been published today, Karol Rutkowski, .

SOUTH SAN FRANCISCO, Calif., April 16, 2018 (GLOBE NEWSWIRE) — Mateon Therapeutics, Inc. (OTCQX:MATN), a biopharmaceutical company developing investigational drugs for the treatment of orphan oncology indications, today provided a business update and announced 2017 financial results.